삼아제약
₩14,150
▲ +10.00
(+0.07%)
Volume: 626
· 2026-09-23
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
62
- 21d momentum +0.7%
- MA aligned bullish
- RSI 63
🎯
Pullback
38
- Near upper Bollinger band
- +1.2% vs 20MA
💎
Value
64
- ROE 1.0%
- Op. margin 11.8%
- -19% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)62.9
MACD-19
MA trendBullish
ATR2.85%
21d mom.+0.7%
63d mom.+11.1%
vs 20MA+1.2%
RVOL(20)0.38×
52w low · 11,950
52w high · 17,480
-19.1% from 52-week high
20d support 13,600
· resistance 14,330
Computed live from daily OHLCV · as of 2026-09-23
🏦 Fundamentals
ROE1.0%
Op. margin11.8%
Net margin12.7%
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2023 | 0.1T | 0.0T | 24.2% |
| 2024 | 0.1T | 0.0T | 25.6% |
| 2025 | 0.1T | 0.0T | 14.1% |
| 2026 | 0.0T | 0.0T | 11.8% |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum +1.43%, daily vol 0.91%. 삼아제약 sits in a mixed regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
+-0억
Institution
+0억
Retail
+0억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-23 | +-0 | +0 | +0 |
| 09-22 | +-0 | +0 | +0 |
| 09-21 | +0 | +0 | +-0 |
| 09-18 | +-0 | +0 | +0 |
| 09-17 | +-0 | +0 | +0 |
Net buy/sell in ₩100M (억). Positive = net buying.